Targeting fibroblast derived thrombospondin 2 disrupts an immune-exclusionary environment at the tumor front in colorectal cancer
Article Details
Authors (38)
Kosuke Iwane
Yuki Nakanishi
Department of Gastroenterology and Hepatology, Graduate School of Medicine, Kyoto University
Yu Muta
Jiayu Chen
Kento Yasumura
Mayuki Omatsu
Department of Gastroenterology and Hepatology, Graduate School of Medicine, Kyoto University
Naoki Aoyama
Munehiro Ikeda
Yoko Masui
Liyang Cai
Go Yamakawa
Kensuke Hamada
Kenta Mizukoshi
Munenori Kawai
Kei Iimori
Shinnosuke Nakayama
Nobukazu Agatsuma
Takahiro Utsumi
Munemasa Nagao
Takahisa Maruno
Department of Gastroenterology and Hepatology, Graduate School of Medicine, Kyoto University
Yukiko Hiramatsu
Nobuyuki Kakiuchi
Masahiro M. Nakagawa
Yasuhiro Fukui
Yukina Kusunoki
Hiroaki Kasashima
Masakazu Fujimoto
Yoshiro Itatani
Toshiaki Kogame
Akihisa Fukuda
Masakazu Yashiro
Kiyoshi Maeda
Kenji Kabashima
Kazutaka Obama
Department of Surgery, Graduate School of Medicine, Kyoto University
Seishi Ogawa
Maria T. Diaz-Meco
Jorge Moscat
Hiroshi Seno
Department of Gastroenterology and Hepatology, Graduate School of Medicine, Kyoto University